Boston, Massachusetts – February 5, 2026 – ArisGlobal, an AI-first technology company at the forefront of life sciences and creator of LifeSphere®,  today announced that YURiA-PHARM has gone live with LifeSphere® Regulatory, marking a milestone in the company’s digital transformation and its commitment to modernizing regulatory operations.

“This milestone reflects our ongoing commitment to modernizing our regulatory operations, said Nataliia Litvinenko, Research and Development Director of YURiA-PHARM “LifeSphere® Regulatory offers a comprehensive, end-to-end platform that supports our teams’ day-to-day work and future goals. We’ve appreciated the steady cooperation throughout this phase of the project.”

The LifeSphere® Regulatory deployment establishes a strong foundation for YURiA-PHARM’s broader modernization roadmap. As the partnership continues, YURiA-PHARM has plans to leverage deeper automation, advanced data integration, and extend implementation with new solutions that are designed to increase speed, transparency, and regulatory readiness across the company.

“YURiA-PHARM’s commitment to digital innovation sets a strong example for other pharmaceutical organizations,” said Zhiyi Chen, Senior Vice President, Customer Excellence, ArisGlobal. “LifeSphere® Regulatory provides a modern, flexible platform designed to evolve with YURiA-PHARM’s needs and helps drive continued operational progress. We are pleased to support their transformation journey.”

The cooperation between YURiA-PHARM and ArisGlobal reflects a shared focus on modernization, operational alignment, and long-term digital readiness.

About YURiA-PHARM

YURiA-PHARM is a leader Ukrainian pharmaceutical manufacturer of consistently high-quality, safe and effective pharmaceutical product that meets the needs of the end user and international regulatory requirements.  The company delivers high-standard healthcare solutions to patients across local and global markets.